SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-024008
Filing Date
2024-03-01
Accepted
2024-03-01 17:03:14
Documents
79
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K etnb-20231231.htm   iXBRL 10-K 2603944
2 EX-4.2 etnb-ex4_2.htm EX-4.2 26079
3 EX-23.1 etnb-ex23_1.htm EX-23.1 2609
4 EX-31.1 etnb-ex31_1.htm EX-31.1 15269
5 EX-31.2 etnb-ex31_2.htm EX-31.2 15281
6 EX-32.1 etnb-ex32_1.htm EX-32.1 13001
7 EX-97.1 etnb-ex97_1.htm EX-97.1 31823
8 GRAPHIC img33031592_0.jpg GRAPHIC 216008
9 GRAPHIC img33031592_1.jpg GRAPHIC 703459
10 GRAPHIC img33031592_2.jpg GRAPHIC 793484
11 GRAPHIC img33031592_3.jpg GRAPHIC 554317
12 GRAPHIC img33031592_4.jpg GRAPHIC 1060421
13 GRAPHIC img186552416_0.jpg GRAPHIC 79869
  Complete submission text file 0000950170-24-024008.txt   18335277

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT etnb-20231231.xsd EX-101.SCH 1413098
81 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20231231_htm.xml XML 1885475
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39122 | Film No.: 24711344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)